{
  "gene": "MSH2",
  "phenotype_entities": [
    {"name": "Lynch syndrome 1", "source_mentions": ["OMIM", "GENEREVIEWS", "ORPHANET"]},
    {"name": "Muir-Torre syndrome", "source_mentions": ["OMIM"]},
    {"name": "Mismatch repair cancer syndrome 2", "source_mentions": ["OMIM"]},
    {"name": "Constitutional mismatch repair deficiency syndrome", "source_mentions": ["ORPHANET"]},
    {"name": "Lynch syndrome", "source_mentions": ["GENEREVIEWS", "ORPHANET"]}
  ],
  "criteria_reasoning": {
    "assertions_made": {
      "verdict": "Multiple entities",
      "justification": "OMIM lists Lynch syndrome 1, Muir-Torre syndrome, and Mismatch repair cancer syndrome 2 as separate entities. GeneReviews treats Muir-Torre features within the Lynch syndrome spectrum, while Orphanet lists Lynch syndrome and Constitutional mismatch repair deficiency syndrome as distinct diseases."
    },
    "molecular_mechanism": {
      "verdict": "Distinct",
      "justification": "Lynch syndrome (including Muir-Torre features) results from heterozygous loss-of-function in MSH2 (autosomal dominant). Constitutional mismatch repair deficiency/MMRCS2 results from biallelic pathogenic variants causing a severe childhood-onset phenotype (autosomal recessive)."
    },
    "phenotypic_variability": {
      "verdict": "Variable expressivity",
      "justification": "Muir-Torre manifestations (sebaceous neoplasms) are presented as part of the Lynch spectrum and are enriched in some MSH2 families, indicating intrafamilial/interfamilial variability. In contrast, the AR condition shows a clearly different, childhood-onset tumor spectrum, supporting separation from AD Lynch syndrome."
    },
    "mode_of_inheritance": {
      "verdict": "Different",
      "justification": "Lynch syndrome is autosomal dominant due to heterozygous MSH2 pathogenic variants. Constitutional mismatch repair deficiency/MMRCS2 is autosomal recessive with biallelic variants and markedly different clinical course and management."
    }
  },
  "entity_decisions": [
    {"name": "Lynch syndrome 1", "decision": "LUMP", "confidence": 0.9},
    {"name": "Muir-Torre syndrome", "decision": "LUMP", "confidence": 0.9},
    {"name": "Lynch syndrome", "decision": "LUMP", "confidence": 0.9},
    {"name": "Mismatch repair cancer syndrome 2", "decision": "LUMP", "confidence": 0.9},
    {"name": "Constitutional mismatch repair deficiency syndrome", "decision": "LUMP", "confidence": 0.9}
  ],
  "proposed_groupings": [
    {
      "group_id": 1,
      "entities": ["Lynch syndrome 1", "Muir-Torre syndrome", "Lynch syndrome"],
      "proposed_label": "Lynch syndrome",
      "mode_of_inheritance": "Autosomal dominant",
      "criteria_met": ["assertions", "phenotypic_variability", "mode_of_inheritance"],
      "reasoning": "GeneReviews includes sebaceous tumors and glioblastoma within Lynch syndrome; OMIM shows Muir-Torre largely due to heterozygous MSH2 variants. Same mechanism (heterozygous LoF) and AD inheritance with variable expressivity support lumping.",
      "decision": "LUMP"
    },
    {
      "group_id": 2,
      "entities": ["Mismatch repair cancer syndrome 2", "Constitutional mismatch repair deficiency syndrome"],
      "proposed_label": "Constitutional mismatch repair deficiency syndrome",
      "mode_of_inheritance": "Autosomal recessive",
      "criteria_met": ["assertions", "mode_of_inheritance", "molecular_mechanism"],
      "reasoning": "OMIM MMRCS2 and Orphanet CMMRD describe the same AR, biallelic MSH2 loss-of-function disorder with early-onset malignancies; these should be unified under a single AR entity.",
      "decision": "LUMP"
    }
  ],
  "overall_decision": {
    "verdict": "SPLIT",
    "summary_reasoning": "Evidence supports two distinct germline disease entities for MSH2: an autosomal dominant Lynch syndrome spectrum (including Muir-Torre features) and an autosomal recessive constitutional mismatch repair deficiency/MMRCS2. They differ in inheritance, age of onset, and clinical management, while variability within the AD spectrum explains Muir-Torre as part of Lynch syndrome.",
    "confidence": 0.95
  },
  "top_supporting_evidence": [
    "OMIM: Gene-Phenotype table lists 'Lynch syndrome 1 (AD)', 'Muir-Torre syndrome (AD)', and 'Mismatch repair cancer syndrome 2 (AR)'.",
    "GeneReviews: 'Lynch syndrome is characterized by an increased risk for colorectal cancer ... brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas)...' indicating Muir-Torre features within LS.",
    "Orphanet: Diseases List shows 'Disease-causing germline mutation(s) in Lynch syndrome' and 'Disease-causing germline mutation(s) in Constitutional mismatch repair deficiency syndrome' as separate conditions for MSH2."
  ],
  "suggested_action_for_curator": [
    "Confirm that Muir-Torre manifestations are captured under the curated Lynch syndrome entity label for MSH2.",
    "Ensure the AR biallelic condition is curated separately under 'Constitutional mismatch repair deficiency syndrome' and not merged with the AD Lynch syndrome spectrum."
  ]
}